JIOFIN The Balance Sheet That Tripled Its Leverage in One Year

From Investment Holding Company to Leveraged Lender, in Twelve Months

The audited FY26 balance sheet makes concrete what the last two quarterly posts kept flagging as a trend in progress: Jio Financial Services has stopped being, primarily, a passive holder of an inherited Reliance Industries equity stake, and has become a real, debt-funded lender. Consolidated loans grew 155.7% in a single year - from Rs. 10,053.12 crore to Rs. 25,710.80 crore - funded by borrowings that grew from Rs. 2,986.77 crore to Rs. 15,809.16 crore (up 429%) and debt securities that grew from Rs. 983.23 crore to Rs. 5,959.20 crore (up 506%). Total consolidated liabilities nearly tripled, from Rs. 10,013.42 crore to Rs. 29,643.49 crore (up 196%), against total assets growing a comparatively modest 22.5% (Rs. 1,33,509.94 crore to Rs. 1,63,497.08 crore). This is a company that took on real leverage for the first time in its listed life - a structural shift, not an incremental one, and exactly the kind of change a reader following only the quarterly PAT headline (see below) would completely miss.

That headline PAT, in fact, moved in the opposite direction of everything above: full-year FY26 consolidated PAT was Rs. 1,560.90 crore, down 3.2% from FY25's Rs. 1,612.59 crore - even as total income grew 70.4% (Rs. 3,542.61 crore vs. Rs. 2,078.92 crore). The entire gap is explained by one line: finance costs went from Rs. 7.65 crore in FY25 to Rs. 745.09 crore in FY26 - a 97x increase, the direct, unavoidable cost of funding the loan-book growth described above with debt rather than the group's own equity. A company growing its lending book 156% in a year should expect funding costs to rise; what's notable is that they rose fast enough to erase the entire 70% revenue gain and then some, at least for now. Q4 FY26 alone told the same story in miniature: PAT of Rs. 272.22 crore, down 13.9% year-on-year (Rs. 316.11 crore in Q4 FY25) despite total income more than doubling (Rs. 1,019.69 crore vs. Rs. 518.36 crore).

In the middle of all this, JFS's Board declared a dividend of Rs. 0.60 per share of face value Rs. 10 for FY26 - up from the Rs. 0.50 per share declared for FY25, JFS's first dividend since listing - subject to shareholder approval at the upcoming AGM. At the same April 17, 2026 board meeting that approved the results, the Board also accepted Group Chief Financial Officer Abhishek Haridas Pathak's request to be released from the role, effective April 20, 2026 (a new CFO, Annapoorna Venkataramanan, was appointed effective May 11, 2026). A raised dividend and a CFO departure disclosed in the same board outcome is a genuinely mixed set of signals for a company one year into building out a leveraged lending balance sheet.

The Prescription

JFS should keep the leverage build-out going - a 22-year-old holding company with a AAA-adjacent parent (Reliance) and a Core Investment Company structure is exactly the kind of entity that should be levering up to fund a loan book, rather than sitting on an inherited equity stake earning dividend yield. The mistake would be pulling back on lending growth because this year's finance-cost jump dented headline PAT - that's the expected, mechanical cost of the strategy working, not evidence the strategy is failing.

What it should stop doing: presenting a raised dividend and a CFO resignation in the same results announcement without addressing the CFO departure's reasons anywhere in the earnings materials or on the call (see Beyond the Usual below). A company three years into its listed life, in the middle of building its most leverage-intensive year yet, owes shareholders more than a bare Regulation 30 disclosure when its most senior finance executive leaves right after signing off on the annual results.

Key Financial Metrics

FY26 (year ended March 31, 2026) vs. FY25 (year ended March 31, 2025), and Q4 FY26 vs. Q4 FY25, consolidated, reported in Rs. crore

FX: Rs. 93.48 = $1 (March 31, 2026 close).

Metric	FY26 (Rs. cr)	FY26 ($)	FY25 (Rs. cr)	YoY	Q4 FY26 (Rs. cr)	Q4 FY25 (Rs. cr)	Q4 YoY
Net Revenue (Total revenue from operations)	3,513.26	$375.8M	2,042.91	✅ +72.0%	1,018.51	493.24	✅ +106.5%
Operating Income (PPOP, before share of Associates/JV)	1,559.68	$166.8M	1,554.09	⚠️ +0.4%	299.70	349.70	⚠️ -14.3%
Net Income (PAT)	1,560.90	$167.0M	1,612.59	⚠️ -3.2%	272.22	316.11	⚠️ -13.9%
Total Comprehensive Income	6,720.28	$718.9M	(15,651.16)	✅ Swung to a gain	(15,756.07)	4,534.26	⚠️ Swung to a loss
Total Cash	715.04	$76.5M	352.32	✅ +103.0%	-	-	-

The balance sheet is where this year's real story lives. As of March 31, 2026, consolidated total assets stood at Rs. 1,63,497.08 crore (Rs. 1,33,509.94 crore a year earlier, +22.5%), with the asset mix shifting meaningfully toward lending: Investments (the legacy portfolio) grew a comparatively modest 11.9% (Rs. 1,18,910.32 crore to Rs. 1,33,088.67 crore), while Loans grew 155.7% (Rs. 10,053.12 crore to Rs. 25,710.80 crore) - the fastest-growing line on the entire balance sheet. On the liabilities side, Debt Securities grew 506% (Rs. 983.23 crore to Rs. 5,959.20 crore) and Borrowings grew 429% (Rs. 2,986.77 crore to Rs. 15,809.16 crore), while Equity grew a much slower 8.4% (Rs. 1,23,496.52 crore to Rs. 1,33,853.59 crore) - consistent with a company funding new growth mostly with debt rather than diluting equity (aside from the warrant issue discussed in Beyond the Usual below, most of which hadn't converted to equity as of this balance-sheet date).

The clearest single number in this entire report: finance costs went from Rs. 7.65 crore to Rs. 745.09 crore in one year. That's not a rounding change - it's the cost of a genuinely new business model showing up in the P&L for the first time, and it's large enough on its own to have turned FY26's 70% revenue growth into a 3.2% profit decline.

Key Operational Metrics

• Consolidated loan book: Rs. 25,710.80 crore as of March 31, 2026, up 155.7% from Rs. 10,053.12 crore a year earlier.
• Consolidated borrowings + debt securities: Rs. 21,768.36 crore combined, up from Rs. 3,970.00 crore a year earlier (+448%) - the funding side of the lending build-out.
• Total cash and cash equivalents: Rs. 715.04 crore, up 103.0% from Rs. 352.32 crore - a company holding materially more liquidity even while levering up its lending book.
• Jio Credit and Jio BlackRock Asset Management AUM figures were not refreshed in this quarter's materials beyond what was disclosed as of September 30, 2025 (see the Q2 FY26 post) - a gap worth watching given how central both businesses are to the leverage story above.
• Still reported under a single consolidated "investing & financing" segment in the audited financial statements - unchanged from every prior quarter, despite the balance sheet now showing genuinely distinct investing and lending books (see The Prescription in the Q2 FY26 post for why this remains a real disclosure gap).

Beyond the Usual

The Group CFO's departure was disclosed at the same board meeting that signed off on the annual results, with no stated reason

At its April 17, 2026 meeting - the same meeting that approved the FY26 annual results - JFS's Board also "took note and accepted the request" of Group Chief Financial Officer Abhishek Haridas Pathak to be released from the CFO and Key Managerial Personnel role, effective April 20, 2026. Annapoorna Venkataramanan was appointed as the new CFO effective May 11, 2026, leaving a roughly three-week gap with no CFO in place. Regulation 30 disclosures of this kind are not required to state a reason, and none was given beyond a reference to Pathak's own resignation letter (with the Board's statement thanking him for his contributions "during the formative years of the Company") - but a CFO departure disclosed in the very same outcome as the most balance-sheet-transformative annual report in the company's listed history (see the leverage build-out above) is a coincidence worth watching for whether it recurs, rather than something to read too much into on its own.

The dividend rose for a second straight year, even as leverage tripled

The Board recommended a final dividend of Rs. 0.60 per equity share (face value Rs. 10) for FY26, up from the Rs. 0.50 per share declared for FY25, subject to shareholder approval at the AGM. On a FY26 EPS of Rs. 2.41 (before exceptional items), that implies a payout ratio^» of roughly 25% - modest, but rising in the same year the company took on the most leverage in its listed history (see the balance-sheet build-out above). This reads as a credibility signal to shareholders (a company confident enough in its balance sheet to keep raising the payout while also funding a rapidly-growing loan book) more than a capital-allocation shift, given the size involved (roughly Rs. 396 crore in aggregate, a small fraction of the Rs. 745 crore increase in finance costs alone).

A wholly-owned reinsurance JV received its regulatory license this quarter

Allianz Jio Reinsurance Limited (the 50:50 JV with Allianz Europe B.V., first disclosed in the Q2 FY26 post) received its certificate of registration from India's insurance regulator (IRDAI) on March 12, 2026, formally clearing it to commence business as a reinsurance company - both partners had contributed Rs. 150 crore each as equity capital during the year. This closes out what was previously a pending regulatory item and adds a seventh operating license to JFS's roster.

A new Alternative Investment Fund manager was incorporated late in the fiscal year

JFS incorporated Jio Alternative Investment Manager Limited (JAIML) on January 23, 2026, as a wholly-owned subsidiary to eventually act as investment manager for an Alternative Investment Fund (AIF) under SEBI's AIF regulations, with an initial Rs. 1 crore invested toward its founding equity - an eighth licensed business line in the pipeline, still pre-launch.

A new employee stock option pool of 3.2 crore shares is proposed

The Board proposed granting up to 3,20,00,000 stock options (exercisable into an equal number of equity shares) to eligible employees across the Company, its subsidiaries, and associates, at fair-market-value exercise prices, subject to shareholder approval at the AGM - roughly 0.5% of the company's post-warrant-conversion share count if fully granted and exercised, a modest dilution relative to the warrant issue discussed below.

Management's Framing: Leverage as a Feature, Not a Warning Sign

CEO Hitesh Sethia's remarks framed the year's balance-sheet transformation entirely in growth terms - AUM scale-up, disbursement growth, new licenses coming online - without directly addressing the finance-cost jump from Rs. 7.65 crore to Rs. 745.09 crore, or connecting it explicitly to the year's flat-to-declining PAT. The call also did not address the CFO transition (see Beyond the Usual above), which had not yet been announced at the time of the April 17 results call but was disclosed just three days later - a reader relying only on the call would have no advance signal of the change.

Coverage Table

Metric	FY26	FY25	YoY	Why it matters
Total revenue from operations	Rs. 3,513.26 cr	Rs. 2,042.91 cr	✅ +72.0%	The business is genuinely growing top-line
PAT	Rs. 1,560.90 cr	Rs. 1,612.59 cr	⚠️ -3.2%	Growth hasn't reached the bottom line yet
Finance costs	Rs. 745.09 cr	Rs. 7.65 cr	⚠️ 97x	The entire explanation for the revenue/profit gap
Loans (balance sheet)	Rs. 25,710.80 cr	Rs. 10,053.12 cr	✅ +155.7%	The real driver behind the finance-cost jump
Total liabilities	Rs. 29,643.49 cr	Rs. 10,013.42 cr	⚠️ +196.0%	First real leverage this company has ever carried

Target Valuation Range

Fair-value range: roughly Rs. 179-211/share (~Rs. 1,13,800-1,33,900 crore, ~$12.1-14.3 billion) - a band at or below book value, reflecting an ROE (~1.2%) still well under a normal cost of equity for a financial-services business. At Rs. 224.10, JFS trades only modestly above that ceiling - fairly valued to slightly expensive on trailing numbers, given a leverage build-out that's genuinely working operationally but hasn't yet proven it can generate returns above its own cost of funding.

JFS's share price fell from Rs. 294.95 at the end of December 2025 to Rs. 224.10 at the end of March 2026, down 24.0% over the quarter - a meaningful decline, and part of a longer slide from the Rs. 377.00 peak in April 2024 (down 40.6% from that peak). This is large enough to warrant a dedicated note: the decline tracks a broader de-rating across Indian NBFCs and financials over the period rather than anything specific in this result, but it also means the market was pricing in less confidence in the leverage build-out even before this quarter's finance-cost jump was fully visible in the audited numbers - worth watching whether the market's read proves prescient or overdone once a full year of the new lending book's returns is visible.

Market cap / book value	Q4 FY2026 (Mar 2026)
Share price (period-end)	Rs. 224.10
Shares outstanding	~6,353,141,623
Market capitalization	Rs. 1,42,371 crore (~$15.2B)
Book value (fresh, audited net worth)	Rs. 1,33,853.59 crore
P/B	~1.06x

Down materially from ~1.51x-1.52x implied over the prior two quarters, both because the price fell and because equity grew. This is the first time this site has been able to compute a fresh P/B off an actual quarter-end balance sheet rather than a stale prior-year figure.

Peer-multiple sanity check	Q3 FY2026 (Dec 2025)	Q4 FY2026 (Mar 2026, FY26 basis)
P/B	~1.52x (stale denominator)	~1.06x
ROE	~1.4% (annualized 9M)	~1.2% (full-year FY26)

Low by any lending-business standard, though this blends a still-dominant, low-yielding legacy investment portfolio with a young, fast-growing loan book that hasn't yet reached the scale where its own returns would move the consolidated number meaningfully.

DCF / reverse DCF: Still not attempted for a full valuation range - a credible multi-year free-cash-flow projection would need the lending business broken out as its own segment (still not disclosed, see The Prescription) with a visible net interest margin^» after funding costs, which this year's numbers don't yet provide cleanly enough to model with confidence.

What would need to be true for the current price to look cheap: the loan book (now Rs. 25,710.80 crore and growing) would need to demonstrate a stable net interest margin comfortably above its funding cost as it scales further, Jio BlackRock AMC and the newly-licensed insurance/reinsurance JVs would need to start contributing visible fee income, and the CFO transition would need to pass without disrupting the reporting discipline this leverage build-out depends on.

---